İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

YUSUF ÖZKAY

PROFESÖR

ANADOLU ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Farmasotik Kimya

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 172
  • Proje 0
  • Kitap 1
  • Bildiri 67
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 51 Q2 67 Q3 30 Q4 13
WoS (JCR) Q1 31 Q2 65 Q3 38 Q4 26
TR Index 6 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 39
Ort. yüzdelik 74.8%
Üst %1 payı 0.0%
Üst %10 payı 27.7%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 172 yayın

Scopus (SJR)
Q1 51 Q2 67 Q3 30 Q4 13
WoS (JCR)
Q1 31 Q2 65 Q3 38 Q4 26
TR Index
6 makale

Makale listesi

  1. 2025 Multi-Target Quinoxaline Derivatives for Alzheimer’s Disease: Inhibitory Activities Against AChE and BACE-1 Enzymes Polycyclic Aromatic Compounds DOI 10.1080/10406638.2024.2442581 YÖKSİS SJR Q3 JCR Q2 OpenAlex 21.6%
  2. 2025 Design, synthesis, and antiproliferative activity evaluation of novel cyclic secondary amine containing dithiocarbamate derivatives as potent EGFR inhibitors Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.142036 YÖKSİS SJR Q2 JCR Q2 OpenAlex 86.9%
  3. 2025 Design and Synthesis of Thiadiazole Derivatives as Dual EGFR/COX-2 Inhibitors with Anticancer and Anti-inflammatory Activities ACS Omega DOI 10.1021/acsomega.5c09752 YÖKSİS SJR Q1 JCR Q2 OpenAlex 86.1%
  4. 2025 Synthesis of new piperazine‐oxadiazole derivatives and investigation of their anticancer activities Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.140298 YÖKSİS SJR Q2 JCR Q2 OpenAlex 69.7%
  5. 2025 Synthesis, biological evaluation and in silico studies of clopidogrel based new 1,2,4-triazole-3-thione derivatives as DNA methyltransferase inhibitors on prostate cancer cells Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.142081 YÖKSİS SJR Q2 JCR Q2 OpenAlex 89.7%
  6. 2025 Targeting Cancer with New Morpholine-Benzimidazole-Oxadiazole Derivatives: Synthesis, Biological Evaluation, and Computational Insights ACS Omega DOI 10.1021/acsomega.5c03795 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 90.4%
  7. 2025 Synthesis and biological evaluation of novel naproxen–phenacetin triazole hybrids as promising anti-inflammatory agents with enhanced gastrointestinal tolerability Bioorganic Chemistry DOI 10.1016/j.bioorg.2025.109000 YÖKSİS SJR Q1 JCR Q1 OpenAlex 11.3%
  8. 2025 Structure-based design, synthesis, and biological activity evaluation of chalcone-piperazine derivatives as dual AChE and MAO B inhibitors RSC Advances DOI 10.1039/D5RA05397H YÖKSİS SJR Q1 JCR Q2 OpenAlex 84.0%
  9. 2025 Synthesis, Characterization, and In vitro and In Silico Studies of New Triazole Derivatives as Aromatase Inhibitors Medicinal Chemistry DOI 10.2174/0115734064316112240722092935 YÖKSİS SJR Q3 JCR Q3 OpenAlex 68.2%
  10. 2025 Exploring SAR and Antifungal Activity of Pyrazole‐Thiazole‐Hydrazone Compounds Through Synthesis and Docking Studies Chemistry & Biodiversity DOI 10.1002/cbdv.202501313 YÖKSİS SJR Q2 JCR Q3 OpenAlex 80.7%
  11. 2025 Innovative Pyrazole–Thiazole–Oxadiazole Hybrid Compounds for Targeted EGFR/VEGFR2 Inhibition in Cancer Treatment Archiv der Pharmazie DOI 10.1002/ardp.70122 YÖKSİS SJR Q2 JCR Q2 OpenAlex 75.5%
  12. 2025 Integrated (modular) education model in pharmacy: The Anadolu University case İstanbul Journal of Pharmacy DOI 10.26650/IstanbulJPharm.2025.1563281 YÖKSİS TR Index JCR Q4 OpenAlex 8.6%
  13. 2024 Design, synthesis, and investigation of biological activities of new triazole derivatives with antifungal effect Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.138277 YÖKSİS SJR Q2 JCR Q2 OpenAlex 86.0%
  14. 2024 Synthesis, characterization, biological evaluation and in silico studies of novel 1,3,4-thiadiazole derivatives as aromatase inhibitors Journal of Molecular Structure DOI 10.1016/j.molstruc.2023.136903 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 91.2%
  15. 2024 Development and assessment of novel pyrazole–thiadiazol hybrid derivatives as VEGFR-2 inhibitors: design, synthesis, anticancer activity evaluation, molecular docking, and molecular dynamics simulation Zeitschrift für Naturforschung C DOI 10.1515/znc-2024-0067 YÖKSİS SJR Q3 JCR Q3 OpenAlex 49.8%
  16. 2024 Novel Hydrazide‐Hydrazones Bearing a Benzimidazole Ring: Design, Synthesis, and Evaluation of Inhibitor Properties Against CA I and CA II Isozymes Chemical Biology & Drug Design DOI 10.1111/cbdd.70025 YÖKSİS SJR Q2 JCR Q2 OpenAlex 50.9%
  17. 2024 Synthesis, DFT Calculations, In Silico Studies, and Antimicrobial Evaluation of Benzimidazole-Thiadiazole Derivatives ACS Omega DOI 10.1021/acsomega.4c00543 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 97.3%
  18. 2024 Metabolic engineering of Saccharomyces cerevisiae for enhanced taxadiene production Microbial Cell Factories DOI 10.1186/s12934-024-02512-z YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 92.7%
  19. 2024 New benzimidazole‐oxadiazole derivatives as potent VEGFR‐2 inhibitors: Synthesis, anticancer evaluation, and docking study Drug Development Research DOI 10.1002/ddr.22218 YÖKSİS SJR Q2 JCR Q1 OpenAlex üst %10 OpenAlex 93.1%
  20. 2024 In Vitro Enzyme Activity and Molecular Docking Studies of Pyrazoline Derivatives as Monoamine Oxidase Inhibitors Pharmaceutical Chemistry Journal DOI 10.1007/s11094-024-03161-7 YÖKSİS SJR Q4 JCR Q4 OpenAlex 44.5%

Akademisyenlere dön